Trial intelligence / Profile preview

Dose-response evaluation of cizolirtine citrate versus placebo in urge urinary incontinence

2004-001119-69Phase 3Completed

Sponsor
Esteve
Start
Sep 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of cizolirtine in urge incontinence (3 arms), sponsored by Esteve. Primary endpoint: Primary endpoint (Part 1). Started Sep 2004; status: completed.

02

Drugs

cizolirtine
03

Conditions

urge incontinence

Beyond the preview

Go deeper on 2004-001119-69.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001119-69.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call